Human coronavirus (HCoV) infections in children represent only a small proportion of respiratory infections requiring hospitalization, according to a study, adding that HCoV infections do not differ significantly from other respiratory viral infections.
Relying on the clinical features of confirmed patients with the novel coronavirus disease (COVID-19) is not enough to diagnose the disease early, suggests a recent study, noting that epidemiologic history is essential in the early detection of COVID-19.
In the treatment of patients with influenza, the combination of pimodivir plus oseltamivir is well tolerated and has pharmacokinetic profiles unaffected by age, according to the results of a phase II trial.
Although real-time quantitative polymerase chain reaction (RT-qPCR) is the gold standard in the diagnosis of SARS-CoV-2 infection, the virus that causes the novel coronavirus disease (COVID-19), it is not exempt from false negatives, reveals a study.
The immunosuppressive drug tocilizumab has the potential to be used as a targeted treatment against cytokine storm related to SARS-CoV-2 infection, reducing inflammation, oxygen requirement, vasopressor support, and death, as shown in a study.
Decreased sense of smell, reduced ability to taste things, or ringing in the ears tend to occur in the early stage of COVID-19, according to a study, suggesting that neurosensory dysfunction could be used as a marker for early diagnosis of the infectious disease.
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.